COMPOUNDS / PSYCHEDELIC / 2C-B
PSYCHEDELIC

2C-B

MEDIUM RISK
BEST FOR:Recreation●●●●●●●○○○7/10
2C-B · 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE · NEXUS · VENUS · EVE · BEES · B · TUCIBI
PsychedelicPhenethylamine2C SeriesSerotoninNPSEntactogen

A synthetic phenethylamine psychedelic with visual, entactogenic, and mild stimulant effects, structurally related to mescaline.

ROUTE / DOSAGE
LOW10-15mg
STANDARD15-25mg
HIGH25-45mg
Note: Most common route; effects last 4-8h
CYCLE
Max 1x per week allow 5-7 days for tolerance reset
BIOAVAILABILITY
~50-60% oral higher intranasal
ACTIVE DURATION
4-8h (subjective)
STORAGE
Room temperature dry away from light protect from moisture
HALF-LIFE
3-4h (plasma)
DURATION BREAKDOWN
Total4-8h
Onset20-40min
Come up30-90min
Peak2-4h
Offset1-2h
After effects1-4h
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
7 documented
Visual hallucinations and enhanced color perception
Tactile and sensory enhancement
Euphoria and mood elevation
Mild stimulant effects including increased heart rate
Altered perception of time and space
Synaesthesia in some users
Body load and physical discomfort at higher doses
§ 02 — RISKS
Cardiovascular effects including elevated blood pressure and tachycardia
Severe hallucinations, agitation, and confusion from accidental ingestion of more potent 2C analogues sold as 2C-B
Acquired synaesthesia reported following use
Impairment of episodic memory encoding and metamemory during acute effects
Misidentification in the drug supply chain (e.g., 'tusi' concoctions rarely contain 2C-B)
Psychological distress including anxiety and panic during acute effects
§ 03 — INTERACTIONS
No interaction with your stack
VIEW STACK
CAUTION
Cannabis
Stimulants
AVOID · DANGEROUS
Lithium
Tramadol
§ 04 — SCIENCE

An observational study in 16 healthy volunteers confirmed that oral 2C-B (10-20 mg) increases blood pressure and heart rate while inducing euphoria, perceptual changes, and mild hallucinations, with peak plasma concentration at approximately 1 hour. A comparative study found that 2C-B and psilocybin similarly distort episodic familiarity during memory encoding, suggesting shared neurocognitive mechanisms across psychedelics. Case reports highlight dangers of misidentification, such as 2C-P being sold as 2C-B, leading to severe toxicity due to higher potency and longer duration. The illicit 'tusi' phenomenon further complicates the landscape, as products sold as 2C-B rarely contain it. Pharmacokinetic and toxicological data remain limited, with most evidence derived from case reports and a single controlled human study.

§ 06 — SOURCES
[1]
Psilocybin and 2C-B at Encoding Distort Episodic Familiarity (PMID 38942147)
pubmed.ncbi.nlm.nih.gov ↗
[2]
Acquired synaesthesia following 2C-B use (PMID 31025060)
pubmed.ncbi.nlm.nih.gov ↗
[3]
Tusi: a new ketamine concoction complicating the drug landscape (PMID 37162319)
pubmed.ncbi.nlm.nih.gov ↗
[4]
Mistaking 2C-P for 2C-B: What a Difference a Letter Makes (PMID 28130544)
pubmed.ncbi.nlm.nih.gov ↗
[5]
Pharmacokinetics, pharmacodynamics and toxicology of NPS: 2C-B, 4-FA and benzofurans (PMID 26530501)
pubmed.ncbi.nlm.nih.gov ↗
[6]
Acute Pharmacological Effects of 2C-B in Humans: An Observational Study (PMID 29593537)
pubmed.ncbi.nlm.nih.gov ↗
[7]
PsychonautWiki - 2C-B
psychonautwiki.org ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT